The study seeks to identify possible biological markers of schizophrenia and the effects of gene-environment interactions on brain structural and functional networks. So we can help doctors and scientific researchers better understand the neuropathological basis of schizophrenia.
Age
13–35
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Age: 13-35 years old(Patients with healthy siblings can be extended to 14-35 years of age)
Course of disease: \<24 months
Priority is given to patients who have never taken medicine or duration of drug use \< 2 weeks
No nuclear magnetic contraindications.
You may not be if
Family history of psychotic disorders, history of psychoactive substances abuse, alcohol dependence, or nicotine dependence
Have a major physical disease or infectious disease
History of coma and serious neurological disease 4.MRI contraindications.
Clareo Health | Psychiatric Multi-omics and Neuroimaging Project
